Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer, Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07732686
What this trial is testing

Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry

Who this might be right for
Pancreas CancerHepatocellular CarcinomaLung Cancer+6 more
University of Oklahoma 2,000
Early research (Phase 1)Study completedNCT03517488
What this trial is testing

XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Who this might be right for
MelanomaBreast CarcinomaHepatocellular Carcinoma+25 more
Xencor, Inc. 150
Not applicableStudy completedNCT02494037
What this trial is testing

The Canadian/US Integrative Oncology Study

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsPancreatic Neoplasms+1 more
The Canadian College of Naturopathic Medicine 400
Not applicableUnknownNCT03979612
What this trial is testing

Evaluation of the Adhesion to the GENEPY Network

Who this might be right for
Hereditary Cancer SyndromeHereditary Breast and Ovarian CancerHereditary Colorectal Endometrial Cancer Syndrome
Institut Claudius Regaud 450
Not applicableStudy completedNCT00444054
What this trial is testing

The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer

Who this might be right for
CancerBreast CancerColon Cancer+3 more
Albert Einstein College of Medicine 10
Not applicableStudy completedNCT01372553
What this trial is testing

Guilford Genomic Medicine Initiative (GGMI)

Who this might be right for
Breast CancerOvarian CancerColon Cancer+1 more
The Moses H. Cone Memorial Hospital 1,184
Testing effectiveness (Phase 2)Study completedNCT04731467
What this trial is testing

CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerPancreatic Cancer+4 more
Famewave Ltd. 79
Not applicableLooking for participantsNCT04494945
What this trial is testing

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Who this might be right for
BRCA1/2-Associated Hereditary Breast and Ovarian Cancer SyndromeBreast Ductal Carcinoma In SituHematopoietic and Lymphoid System Neoplasm+3 more
OHSU Knight Cancer Institute 27,500
Testing effectiveness (Phase 2)Ended earlyNCT06760702
What this trial is testing

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers

Who this might be right for
Ovarian CancerColorectal CancerRenal Cancer
Aurigene Discovery Technologies Limited 29
Not applicableTemporarily pausedNCT03253575
What this trial is testing

CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2

Who this might be right for
Adult Solid Tumor
Mitra RxDx, Inc. 800
Large-scale testing (Phase 3)Study completedNCT00033605
What this trial is testing

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Who this might be right for
Cervical CancerColorectal CancerDiarrhea+8 more
Alliance for Clinical Trials in Oncology 130
Testing effectiveness (Phase 2)Ended earlyNCT04066894
What this trial is testing

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

Who this might be right for
Low Anterior Resection SyndromeMalignant Anal NeoplasmMalignant Bladder Neoplasm+8 more
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT00508573
What this trial is testing

Registry for Women Who Are At Risk Or May Have Lynch Syndrome

Who this might be right for
Hereditary Nonpolyposis Colorectal CancerLynch Syndrome
M.D. Anderson Cancer Center 323
Testing effectiveness (Phase 2)Study completedNCT00959647
What this trial is testing

Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

Who this might be right for
Ovarian CancerBasal Cell CarcinomaMetastatic Colorectal Cancer
Genentech, Inc. 19
Early research (Phase 1)Study completedNCT00581815
What this trial is testing

Spectroscopy With Surface Coils and Decoupling

Who this might be right for
Adrenal Cortical CancerBrain CancerBreast Cancer+16 more
Memorial Sloan Kettering Cancer Center 582
Not applicableNo Longer AvailableNCT03554434
What this trial is testing

An Expanded Access Program for AM0010 (Pegilodecakin)

Who this might be right for
MelanomaProstate CancerOvarian Cancer+6 more
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Early research (Phase 1)Active Not RecruitingNCT05462717
What this trial is testing

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more
Revolution Medicines, Inc. 222
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Early research (Phase 1)Study completedNCT03096054
What this trial is testing

A Phase I Trial of LY3143921 Hydrate in Solid Tumours

Who this might be right for
Colorectal CancerHigh Grade Serous Ovarian CancerNon Small-cell Lung Cancer (Squamous Cell Variant)+4 more
Cancer Research UK 69
Next Page